Epidemiological markers of group A streptococcal infections in France

Julien Loubinoux1, Martine Florent, Bensalem Merad

  • 1Centre National de Référence des Streptocoques - Service de Microbiologie, Hôtel Dieu Assistance Publique - Hôpitaux de Paris, Université Paris VI, 1 place du Parvis Notre-Dame, F-75181 Paris Cedex 04, France. j.loubinoux@viola.fr

Abstract

Insights

Group A Streptococcus invasive isolates are frequently linked to biotype 1, T-type 1, and emm-type 1. Non-invasive strains often show T-type 28 and emm-type 28, crucial for understanding epidemiology and vaccine development.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Certain Group A Streptococcus (GAS) biotypes, T-types, and emm-types are associated with invasive infections.
  • The M protein of GAS is vital for virulence and serves as an important epidemiological marker.

Purpose of the Study:

  • To compare epidemiological markers in invasive and non-invasive clinical isolates of Group A Streptococcus.
  • To identify specific T-types and emm-types prevalent in invasive versus non-invasive GAS infections in France.

Main Methods:

  • A study was conducted in France between 1998 and 2001.
  • 141 invasive and 353 non-invasive GAS isolates were analyzed.
  • Biotype, T-type, and emm-type were determined for all isolates.

Main Results:

  • Invasive isolates were primarily from blood, while non-invasive isolates were from throat swabs.
  • Biotype 1 was common in most isolates.
  • Invasive isolates were predominantly T-type 1/emm-type 1, with T-type 4/emm-type 4 and T-type 28/emm-type 28 also frequent.
  • T-type 28/emm-type 28 was common in invasive isolates causing puerperal sepsis and in non-invasive isolates.

Conclusions:

  • The study confirms a high prevalence of biotype 1, T-type 1, and emm-type 1 among invasive GAS isolates.
  • emm-type 28/T-type 28 was frequently found in non-invasive GAS isolates.
  • Ongoing prospective studies will update emm-type prevalence in France, aiding future vaccine development.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...